Growth in this market is being driven by strong, double-digit growth in unit sales as the market transitions to power-injectable devices from conventional PICCs
Vancouver, BC (PRWEB) June 03, 2014
Vancouver, BC - According to a new report by iData Research (http://www.idataresearch.com), the leading global authority in medical device and pharmaceutical market research, the European Peripherally Inserted Central Catheter (PICC) Market is expected to grow to over $45 million by 2020. The growth is driven by the increasing conversion from devices such as Chronic Central Venous Catheters (CVC) and Peripheral Intravenous Catheters (PIVC). The PICC Market is comprised of the Conventional Peripherally Inserted Central Catheters and the Power-Injectable Peripherally Central Catheters markets.
The latest statistics from Cancer Research UK reports that there were 434,115 cases of cancer diagnosed within the 40 and older population in 2011. The increasing incidence of cancer patients requiring chemotherapy and prolonged IV antibiotic treatment will attribute to the rise in demand for PICCs.
One of the strongest segments driving the European PICC market is the Power-Injectable PICC’s. By 2020, power-injectable PICCs will increase as a percentage of total unit sales from 51% to over 70% in Europe. “Growth in this market is being driven by strong, double-digit growth in unit sales as the market transitions to power-injectable devices from conventional PICCs,” states Dr. Kamran Zamanian, CEO of iData Research. Benelux and Switzerland are expected to transition to using power-injectable devices faster than other regions in Europe, with the Benelux region expected to reach 100% conversion by 2020.
New technological developments will focus on the reduction of infection rates and thrombosis, such as Antithrombogenic PICCs. C. R. Bard is set to launch an antimicrobial PICC family as well as a Thromboresistant PICC product.
Leading the market for European Peripherally Inserted Central Catheter (PICC) Market is C.R. Bard, which has separated its product lines into those used by interventional radiologists such as the POWERPICC® catheter and POWERPICC® Solo® catheter; and for nurses which include the Q-Cath® and Poly Per-Q-Cath®. Other major players driving market growth includes Medcomp, Vygon, Cook Medical, AngioDynamics, B. Braun and Teleflex.
For Further Information
The global series on the Markets for Vascular Access Devices covers U.S and 15 Countries in Europe, Japan, Australia, South Korea and Brazil. The full reports provide a comprehensive analysis including procedure numbers, units sold, market value, forecasts, as well as a detailed competitive market shares and analysis of major players’ success strategies in each market and segment. This market for Vascular Access Devices includes the implantable port, port needle, central venous catheter, peripherally inserted central catheter, peripheral intravenous catheter, dialysis catheter, ultrasound vascular access device and accessories, catheter securement device and, syringe and needle market.
Receive a free synopsis of the European Markets for Vascular Access Devices 2014 Market Research Report
About iData Research
iData Research (http://www.idataresearch.com) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Diabetes Drugs, Diabetes Devices, Pharmaceuticals, Anesthesiology, Wound Management, Orthopedics, Cardiovascular, Ophthalmic, Endoscopy, Gynecology, Urology and more.